Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will report its fourth quarter 2022 financial results on March 2, 2023, after market close. A conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET to discuss these results. The company specializes in next-generation sequencing and multiomics technologies, with products like the G4 Sequencing Platform designed for rapid and accurate genomic results. Additionally, the PX system is in development to analyze RNA and proteins at the single-cell level. Interested investors can access the call via a live and archived webcast.

Positive

• The G4 Sequencing Platform offers fast and accurate genomic results.
• Development of the PX system aims to enhance analysis at the single-cell level.

Negative

• None.

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter 2022 after the market close on Thursday, March 2, 2023. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In development, the PX system leverages Singular’s proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. With these products, Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

What date will Singular Genomics report its Q4 2022 financial results?

Singular Genomics will report its Q4 2022 financial results on March 2, 2023.

What time is the conference call for discussing the financial results?

The conference call is scheduled for 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I listen to the Singular Genomics conference call?

Investors can access the conference call via a live and archived webcast on Singular Genomics' investor relations website.

What technologies does Singular Genomics develop?

Singular Genomics develops next-generation sequencing and multiomics technologies.

What is the purpose of the PX system in development by Singular Genomics?

The PX system aims to analyze RNA and proteins within single cells and tissues.